• Anti-Cytokeratin 20 antibody [K2 20.8] (STJ16101720)

Anti-Cytokeratin 20 antibody [K2 20.8] (STJ16101720)

SKU:
STJ16101720-1

£1,092.50
Shipping:
Free Shipping
Current Stock:
Host: Mouse
Applications: IHC-P
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Cytokeratin 20 is suitable for use in Immunohistochemistry research applications.
Clonality: Monoclonal
Clone ID: K2 20.8
Conjugation: Unconjugated
Isotype: IgG2ak
Formulation: PBS (pH 7.6) with 1% BSA and sodium azide
Concentration: >=9, 26 mg/L
Dilution Range: IHC-P 1:50
Storage Instruction: Store at 2-8°C upon receipt.
Immunogen: Cytoskeletal preparation isolated from microdissected villi of human duodenal mucosa.
Background Cytokeratin 20 has been demonstrated to be almost entirely confined to the gastric and intestinal epithelium, urothelium and Merkel cells of the skin. Cytokeratin 20 is less acidic than other type I cytokeratins and is of interest due to its restricted tissue expression. In normal tissue, cytokeratin 20 is expressed in intestinal epithelium, gastric foveolar epithelium, a number of endocrine cells in the upper portions of the pyloric glands, urothelium and Merkel cells in epidermis. In tumors it is reported, there is a marked difference in the expression of cytokeratin 20 within different carcinomas. Neoplasms expressing cytokeratin 20 are derived from normal epithelia which themselves expressed cytokeratin 20. Colorectal carcinomas consistently express cytokeratin 20, while gastric adenocarcinomas express cytokeratin 20 to a lesser degree. Adenocarcinomas of the gall bladder and bile duct, ductal cell adenocarcinomas of the pancreas, mucinous ovarian tumors, Merkel cell tumors and transitional cell carcinomas have also been reported to express cytokeratin 20.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance